These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 9568641

  • 21. Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer.
    Osborne CK, Coronado-Heinsohn EB, Hilsenbeck SG, McCue BL, Wakeling AE, McClelland RA, Manning DL, Nicholson RI.
    J Natl Cancer Inst; 1995 May 17; 87(10):746-50. PubMed ID: 7563152
    [Abstract] [Full Text] [Related]

  • 22. Partial antagonism between steroidal and nonsteroidal antiestrogens in human breast cancer cell lines.
    Müller V, Jensen EV, Knabbe C.
    Cancer Res; 1998 Jan 15; 58(2):263-7. PubMed ID: 9443403
    [Abstract] [Full Text] [Related]

  • 23. Plasminogen binding and activation at the breast cancer cell surface: the integral role of urokinase activity.
    Stillfried GE, Saunders DN, Ranson M.
    Breast Cancer Res; 2007 Jan 15; 9(1):R14. PubMed ID: 17257442
    [Abstract] [Full Text] [Related]

  • 24. Modulation of plasminogen activator systems by matrix components in two breast cancer cell lines: MCF-7 and MDA-MB-231.
    Pourreau-Schneider N, Delori P, Boutière B, Arnoux D, George F, Sampol J, Martin PM.
    J Natl Cancer Inst; 1989 Feb 15; 81(4):259-66. PubMed ID: 2492346
    [Abstract] [Full Text] [Related]

  • 25. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ, Jordan VC.
    Cancer Res; 1996 May 15; 56(10):2321-30. PubMed ID: 8625307
    [Abstract] [Full Text] [Related]

  • 26. Regulation of DNA methylation in human breast cancer. Effect on the urokinase-type plasminogen activator gene production and tumor invasion.
    Guo Y, Pakneshan P, Gladu J, Slack A, Szyf M, Rabbani SA.
    J Biol Chem; 2002 Nov 01; 277(44):41571-9. PubMed ID: 12198113
    [Abstract] [Full Text] [Related]

  • 27. Antiestrogens prevent the stimulatory effects of L-triiodothyronine on cell proliferation.
    Zhou-Li F, Albaladejo V, Joly-Pharaboz MO, Nicolas B, Andre J.
    Endocrinology; 1992 Mar 01; 130(3):1145-52. PubMed ID: 1537281
    [Abstract] [Full Text] [Related]

  • 28. The steroidal antiestrogen ICI 182,780 is an inhibitor of cellular aromatase activity.
    Long BJ, Tilghman SL, Yue W, Thiantanawat A, Grigoryev DN, Brodie AM.
    J Steroid Biochem Mol Biol; 1998 Nov 01; 67(4):293-304. PubMed ID: 9883986
    [Abstract] [Full Text] [Related]

  • 29. Invasive capacity and regulation of urokinase-type plasminogen activator in estrogen receptor (ER)-negative MDA-MB-231 human breast cancer cells, and a transfectant (S30) stably expressing ER.
    Long BJ, Rose DP.
    Cancer Lett; 1996 Feb 06; 99(2):209-15. PubMed ID: 8616826
    [Abstract] [Full Text] [Related]

  • 30. Estradiol modulation of plasminogen activator production in organ cultures of human breast carcinomas: correlation with clinical outcome of anti-estrogen therapy.
    Mira-y-Lopez R, Osborne MP, DePalo AJ, Ossowski L.
    Int J Cancer; 1991 Apr 01; 47(6):827-32. PubMed ID: 1901298
    [Abstract] [Full Text] [Related]

  • 31. The paracrine stimulation of MCF-7 cells by MDA-MB-231 cells: possible role in antiestrogen failure.
    Robinson SP, Jordan VC.
    Eur J Cancer Clin Oncol; 1989 Mar 01; 25(3):493-7. PubMed ID: 2703004
    [Abstract] [Full Text] [Related]

  • 32. A comparison of the antitumor activity of two triarylcyclopropyl antiestrogens (compounds 4d and 5c) on human breast cancer cells in culture.
    Jain PT, Pento JT, Magarian RA.
    Anticancer Drugs; 1994 Aug 01; 5(4):429-36. PubMed ID: 7949247
    [Abstract] [Full Text] [Related]

  • 33. Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.
    Montano MM, Ekena K, Krueger KD, Keller AL, Katzenellenbogen BS.
    Mol Endocrinol; 1996 Mar 01; 10(3):230-42. PubMed ID: 8833652
    [Abstract] [Full Text] [Related]

  • 34. interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (faslodex, fulvestrant).
    Bouker KB, Skaar TC, Fernandez DR, O'Brien KA, Riggins RB, Cao D, Clarke R.
    Cancer Res; 2004 Jun 01; 64(11):4030-9. PubMed ID: 15173018
    [Abstract] [Full Text] [Related]

  • 35. Laminin and estradiol regulation of the plasminogen-activator system in MCF-7 breast-carcinoma cells.
    Sonohara S, Mira-y-Lopez R, Brentani MM.
    Int J Cancer; 1998 Mar 30; 76(1):77-85. PubMed ID: 9533765
    [Abstract] [Full Text] [Related]

  • 36. Synthesis and biological evaluation of basic side chain derivatives of Analog II as pure antiestrogens and antitumor agents.
    Magarian RA, Avor KS, Overacre LB, Kunchandy J, Paxton TR.
    Anticancer Drug Des; 1995 Jun 30; 10(4):311-31. PubMed ID: 7786397
    [Abstract] [Full Text] [Related]

  • 37. Plasminogen activators in human breast cancer cell lines: hormonal regulation and properties.
    Mangel WF, Toledo DL, Nardulli AM, Reiner GC, Norman MJ, Katzenellenbogen BS.
    J Steroid Biochem; 1988 Jun 30; 30(1-6):79-88. PubMed ID: 3386280
    [Abstract] [Full Text] [Related]

  • 38. Cross-resistance of triphenylethylene-type antiestrogens but not ICI 182,780 in tamoxifen-stimulated breast tumors grown in athymic mice.
    Lee ES, Schafer JM, Yao K, England G, O'Regan RM, De Los Reyes A, Jordan VC.
    Clin Cancer Res; 2000 Dec 30; 6(12):4893-9. PubMed ID: 11156249
    [Abstract] [Full Text] [Related]

  • 39. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells.
    Gong Y, Ballejo G, Murphy LC, Murphy LJ.
    Cancer Res; 1992 Apr 01; 52(7):1704-9. PubMed ID: 1551100
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens.
    Gottardis MM, Jiang SY, Jeng MH, Jordan VC.
    Cancer Res; 1989 Aug 01; 49(15):4090-3. PubMed ID: 2743303
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.